cta-logo01
  • News

    Most Read

    • Atossa reports positive results from Covid-19 nasal spray study
    • Leidos to conduct clinical trials for Covid-19 therapeutics
    • Pfizer and BioNTech to test Covid-19 vaccine against new variants

    Most Recent

    Clinical Trials

    Atossa reports positive results from Covid-19 nasal spray study

    26 Feb 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Rare diseases: how can decentralisation speed up trials and reduce patient burden?
    • IQVIA’s Nagaraja Srivatsan: decentralised trials and the future of clinical research
    • Neurology trends: Stroke leads Twitter mentions in Q4 2020

    Most Recent

    Clinical Trials

    Rare diseases: how can decentralisation speed up trials and reduce patient burden?

    26 Feb 2021
  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • Atossa reports positive results from Covid-19 nasal spray study
    • Leidos to conduct clinical trials for Covid-19 therapeutics
    • South and Central America accounts for 2.8hare of global clinical trial activity in 2020

    Most Recent

    Clinical Trials

    Atossa reports positive results from Covid-19 nasal spray study

    26 Feb 2021
  • Themes
  • Deals

    Most Read

    • Altasciences completes acquisition of US-based CRO WCCT Global
    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink

    Most Recent

    Clinical Trials

    Altasciences completes acquisition of US-based CRO WCCT Global

    19 Feb 2021
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Kolabtree
    • VaLea Clinical Trials
    • Linari NanoTech

    Most Recent

    Clinical Trials

    Kolabtree

    24 Feb 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
AzurRx BioPharma adds two additional clinical trial sites in Poland

AzurRx BioPharma adds two additional clinical trial sites in Poland

AzurRx BioPharma has added two additional clinical trial sites in Poland to reduce any potential...

27th January 2021
Cyxone screens first patient in Phase II Covid-19 trial

Cyxone screens first patient in Phase II Covid-19 trial

Cyxone has announced the screening of the first participant in the Phase II clinical trial...

18th January 2021
Cyxone to begin Phase II trial of oral Covid-19 drug

Cyxone to begin Phase II trial of oral Covid-19 drug

Cyxone is set to initiate a Phase II clinical trial with Rabeximod in moderate Covid-19...

9th December 2020
WPD and CNS partner for paediatric brain cancer trial

WPD and CNS partner for paediatric brain cancer trial

WPD Pharmaceuticals and CNS Pharmaceuticals are set to initiate a Phase I clinical trial for...

13th February 2020
Moleculin augments two anti-cancer clinical trials in Poland

Moleculin augments two anti-cancer clinical trials in Poland

Moleculin has undertaken and enrolled patients in two anti-cancer clinical trials in Poland.

1st May 2019
M&As this week: Orion Biotechnology Canada, SOPHiA GENETICS, GI Partners

M&As this week: Orion Biotechnology Canada, SOPHiA GENETICS, GI Partners

Orion Biotechnology Canada has completed the acquisition of K2Biomedical for an undisclosed sum.

22nd June 2018
Deals this week: Ultragenyx Pharmaceutical, Insmed, Harbour BioMed

Deals this week: Ultragenyx Pharmaceutical, Insmed, Harbour BioMed

US-based biopharmaceutical company Ultragenyx Pharmaceutical Inc has announced a public offering of shares of its...

26th January 2018

Latest News

Clinical Trials

Atossa reports positive results from Covid-19 nasal spray study

26 Feb 2021
Clinical Research

Leidos to conduct clinical trials for Covid-19 therapeutics

26 Feb 2021
Clinical Trials

Pfizer and BioNTech to test Covid-19 vaccine against new variants

26 Feb 2021
Clinical Trials

GSK to amend Covid-19 study to confirm efficacy in older patients

26 Feb 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
CTArena_white-logo_

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more